Pediatr. praxi. 2015;16(1):24-27

Fractured child - recommendation for diagnostics and treatment

doc.MUDr.Zdeněk Šumník, Ph.D., MUDr.Ondřej Souček Ph.D.
Pediatrická klinika UK 2. LF a FN v Motole, Praha

The International Society for Clinical Densitometry has recently published new guidelines for diagnostics of osteoporosis in children.

These recommendations cope with the diagnostics of children with repeated fractures in a very precise and comprehensive

way. Calcium, vitamin D and an adequate physical activity are frequently used for the prophylaxis of osteoporosis, bisphosphonates

should be administered in the most severe cases. Other therapeutic possibilities (parathormone, denosumab) are a topic of upcoming

clinical studies.

Keywords: osteoporosis, bone density, calcium, vitamin D, children

Published: February 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šumník Z, Souček O. Fractured child - recommendation for diagnostics and treatment. Pediatr. praxi. 2015;16(1):24-27.
Download citation

References

  1. Hedström EM, Svensson O, Bergström U, Michno P. Epidemiology of fractures in children and adolescents. Acta Orthop 2010; 81(1): 148-153. Go to original source... Go to PubMed...
  2. Bishop N, Arundel P, Clark E, Dimitri P, Farr J, Jones G, Makitie O, Munns CF, Shaw N; International Society of Clinical Densitometry. Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 Pediatric Official Positions. J Clin Densitom 2014; 17(2): 275-280. Go to original source... Go to PubMed...
  3. Šumník Z, Souček O. Diagnostika osteoporózy u dětí. Pediatr.praxi 2011; 12(4): 232-234.
  4. Golden NH, Abrams SA. Committee on Nutrition. Optimizing bone health in children and adolescents. Pediatrics 2014; 134(4): e1229-1243. Go to original source... Go to PubMed...
  5. Winzenberg TM, Shaw K, Fryer J, Jones G. Calcium supplementation for improving bone mineral density in children. Cochrane Database Syst Rev. 2006 Apr 19; (2): CD005119. Go to original source... Go to PubMed...
  6. Shaw NJ, Mughal MZ. Vitamin D and child health: part 2 (extraskeletal and other aspects). Arch Dis Child 2013; 98(5): 368-372. Go to original source... Go to PubMed...
  7. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96(1): 53-58. Go to original source... Go to PubMed...
  8. Heaney RP, Holick MF. Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 2011; 26(3): 455-457. Go to original source... Go to PubMed...
  9. Winzenberg TM, Powell S, Shaw KA, Jones G. Vitamin D supplementation for improving bone mineral density in children. Cochrane Database Syst Rev 2010; (10): CD006944. Go to original source...
  10. Simpson M, Brady H, Yin X, Seifert J, Barriga K, Hoffman M, Bugawan T, Barón AE, Sokol RJ, Eisenbarth G, Erlich H, Rewers M, Norris JM. No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia 2011; 54(11): 2779-2788. Go to original source... Go to PubMed...
  11. Tenforde AS, Fredericson M. Influence of sports participation on bone health in the young athlete: a review of the literature. PM R 2011; 3(9): 861-867. Go to original source... Go to PubMed...
  12. Löfgren B, Dencker M, Nilsson JA, Karlsson MK. A 4-year exercise program in children increases bone mass without increasing fracture risk. Pediatrics 2012; 129(6): e1468-e1476. Go to original source... Go to PubMed...
  13. Dwan K, Phillipi CA, Steiner RD, Basel D. Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev 2014; 7: CD005088. Go to original source... Go to PubMed...
  14. Sumnik Z, Land C, Rieger-Wettengl G, Körber F, Stabrey A, Schoenau E. Effect of pamidronate treatment on vertebral deformity in children with primary osteoporosis. A pilot study using radiographic morphometry. Horm Res 2004; 61(3): 137-142. Go to original source... Go to PubMed...
  15. Boyce AM, Chong WH, Yao J, Gafni RI, Kelly MH, Chamberlain CE, Bassim C, Cherman N, Ellsworth M, Kasa-Vubu JZ, Farley FA, Molinolo AA, Bhattacharyya N, Collins MT. Denosumab treatment for fibrous dysplasia. J Bone Miner Res 2012; 27(7): 1462-1470. Go to original source... Go to PubMed...
  16. Semler O, Netzer C, Hoyer-Kuhn H, Becker J, Eysel P, Schoenau E. First use of the RANKL antibody denosumab in osteogenesis imperfecta type VI. J Musculoskelet Neuronal Interact 2012; 12(3): 183-188.




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.